Deficiency of Interleukin-1 Receptor Antagonist: New Genetic Autoinflammatory Disease as a Diagnostic Challenge for Pediatricians

Abstract

Deficiency of interleukin-1 receptor antagonist is a rare autoinflammatory disease that affects infants early in life. It often presents with systemic inflammation, skin and bone involvement. We present a 5-month-old boy who was hospitalized due to generalized erythematous pustular eruption with secondary impetigo, cellulitis, bronchiolitis, and elevated inflammatory markers. The patient was unresponsive to multiple courses of intravenous antibiotics, systemic, and topical steroid medications. The patient was evaluated by dermatology and rheumatology services among other subspecialities. Skin biopsy showed changes consistent with psoriasiform dermatitis, while bone scans showed multifocal osteomyelitis. The patient was started empirically on anakinra with improvement at 72 hours upon administration. This is one of the youngest reported case in the literature to be started on anakinra empirically prior to genetic confirmation of the mutation. A comprehensive literature review revealed that approximately 20 genetically confirmed patients, including our patient, have been reported with this genetic disease. It is imperative to recognize this disease early to achieve adequate response and remission. Therefore, clinical symptoms and the associated differential diagnosis for this disease should be constantly reassessed and reviewed by pediatricians and subspecialists to detect the disease as early as possible and reduce the high morbidity and mortality associated with delayed diagnosis and treatment.

Keywords

deficiency of interleukin-1 receptor antagonist - autoinflammatory disease - pediatrics

Publication History

Received: 01 November 2020

Accepted: 13 January 2021

Article published online:
03 March 2021

• References

• 1 Aksentijevich I, Masters SL, Ferguson PJ. et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009; 360 (23) 2426-2437
• 2 Touitou I, Galeotti C, Rossi-Semerano L, Hentgen V, Piram M, Koné-Paut I. CeRéMAI, French reference center for autoinflammatory diseases. The expanding spectrum of rare monogenic autoinflammatory diseases. Orphanet J Rare Dis 2013; 8 (01) 162
• 3 Cowen EW, Goldbach-Mansky R. DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?. Arch Dermatol 2012; 148 (03) 381-384
• 4 Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 2012; 167 (03) 391-404
• 5 Gery I, Gershon RK, Waksman BH. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med 1972; 136 (01) 128-142
• 6 Rosenstreich DL, Vogel SN, Jacques AR, Wahl LM, Oppenheim JJ. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J Immunol 1978; 121 (05) 1664-1670
• 7 Verbsky JW. Monogenic causes of inflammatory disease in rheumatology. Curr Opin Rheumatol 2012; 24 (05) 506-514
• 8 Minkis K, Aksentijevich I, Goldbach-Mansky R. et al. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Arch Dermatol 2012; 148 (06) 747-752
• 9 Brau-Javier CN, Gonzales-Chavez J, Toro JR. Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra. Arch Dermatol 2012; 148 (03) 301-304
• 10 Reddy S, Jia S, Geoffrey R. et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med 2009; 360 (23) 2438-2444
• 11 Cassidy JT, Petty RE, Laxer RM, Lindsley CB. 2010. Textbook of Pediatric Rheumatology E-Book. Elsevier Health Sciences;
• 12 Diaz A. 2019. Deficiency of the Interleukin-1 Receptor Antagonist (DIRA). In Auto-Inflammatory Syndromes. Springer; Cham, Switzerland: 69-83